Timo T Myöhänen

11PUBLICATIONS
27CO-AUTHORS
Proteins and peptidesNeurology and neuromuscular diseasesPredictive and prognostic markersToxicology (incl. clinical toxicology)Autonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 28, 2024
5-Aminothiazoles Reveal a New Ligand-Binding Site on Prolyl Oligopeptidase Which is Important for Modulation of Its Protein-Protein Interaction-Derived Functions.

Henri T Pätsi, Tommi P Kilpeläinen, Mikael Jumppanen

|May 29, 2023
Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands with Disease-Modifying Effects on α-Synuclein Mouse Models of Parkinson's Disease.

Tommi P Kilpeläinen, Henri T Pätsi, Reinis Svarcbahs

|Apr 12, 2023
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy.

Tony S Eteläinen, M Catarina Silva, Johanna K Uhari-Väänänen

|Sep 06, 2021
Prolyl oligopeptidase inhibition reduces alpha-synuclein aggregation in a cellular model of multiple system atrophy.

Hengjing Cui, Tommi Kilpeläinen, Lydia Zouzoula

|Jul 01, 2021
Deletion or inhibition of prolyl oligopeptidase blocks lithium-induced phosphorylation of GSK3b and Akt by activation of protein phosphatase 2A.

Timo T Myöhänen, Freke Mertens, Susanna Norrbacka

|Feb 13, 2021
Prolyl Oligopeptidase Regulates Dopamine Transporter Oligomerization and Phosphorylation in a PKC- and ERK-Independent Manner.

Ulrika H Julku, Maria Jäntti, Reinis Svarcbahs

Pageof 2

Frequent Collaborators

4 joint publications

Ulrika H Julku

4 joint publications

Reinis Svarcbahs

3 joint publications

Hengjing Cui

3 joint publications

Tommi P Kilpeläinen